Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

Asthma is a common respiratory disease in modern society. However, people are rarely aware of the symptoms of asthma because the early stage of asthma is similar to that of the common cold (e.g., ...

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

A new study has found that while biologic drugs have helped many people with severe asthma manage their symptoms, they may not completely get rid of the immune cells that ...

Why asthma often comes back—even with powerful drugs Date: June 27, 2025 Source: Karolinska Institutet Summary: Biological drugs have been a game-changer for people with severe asthma, helping ...

While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some immune cells with high inflammatory potential are not completely ...